Quartz Bio Supports Debiopharm Group Precision Medicine Bioinformatics

News   Jul 05, 2013

 
Quartz Bio Supports Debiopharm Group Precision Medicine Bioinformatics
 
 
 

RELATED ARTICLES

Possible Biomarker to Identify Who Would Benefit from Immunotherapy

News

While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.

READ MORE

Longevity Protein Could Help Treat Diabetes

News

beta-Klotho, a protein that regulates longevity, could have therapeutic potential for diabetes and obesity.

READ MORE

LogicTRN Model Illuminates Regulatory Gene Framework

News

A newly devised algorithm called LogicTRN has the potential to unravel the complexities of genetic regulation.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Informatics & Automation Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE